Largest health care companies — Page 2
The 1,019 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.815 T
10.5% of all US-listed value
Companies
1,019
Ranked #4 of 12 sectors
Average
$9.632 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 101 | RepligenRGEN | $10.8B | $168.39 | -5.50% | United States |
| 102 | Ensign GroupENSG | $10.7B | $182.60 | -3.03% | United States |
| 103 | QiagenQGEN | $10.5B | $50.87 | +0.07% | Netherlands |
| 104 | Oscar HealthOSCR | $10.2B | $33.14 | -5.83% | United States |
| 105 | VaxcytePCVX | $9.84B | $62.18 | -5.33% | United States |
| 106 | Henry ScheinHSIC | $9.44B | $85.41 | -3.21% | United States |
| 107 | Madrigal PharmaceuticalsMDGL | $9.30B | $400.30 | -0.03% | United States |
| 108 | Spyre TherapeuticsSYRE | $9.21B | $96.94 | -2.12% | United States |
| 109 | Krystal BiotechKRYS | $8.92B | $300.86 | -3.21% | United States |
| 110 | Tg TherapeuticsTGTX | $8.87B | $57.98 | -5.92% | United States |
| 111 | Protagonist TherapeuticsPTGX | $8.76B | $135.31 | -5.62% | United States |
| 112 | ImmunityBioIBRX | $8.48B | $8.01 | -10.36% | United States |
| 113 | Arrowhead PharmaceuticalsARWR | $8.11B | $57.44 | -6.83% | United States |
| 114 | PACS GroupPACS | $7.97B | $50.23 | -0.06% | United States |
| 115 | Twist BioscienceTWST | $7.95B | $119.94 | -15.88% | United States |
| 116 | Corcept TherapeuticsCORT | $7.86B | $71.82 | -9.35% | United States |
| 117 | CytokineticsCYTK | $7.74B | $55.58 | -12.61% | United States |
| 118 | AlkermesALKS | $7.50B | $44.63 | -2.75% | Ireland |
| 119 | Caris Life SciencesCAI | $7.49B | $26.12 | -21.37% | United States |
| 120 | AbivaxABVX | $7.35B | $84.25 | -5.86% | France |
| 121 | Praxis Precision MedicinesPRAX | $7.34B | $263.01 | -7.65% | United States |
| 122 | Rhythm PharmaceuticalsRYTM | $7.21B | $104.00 | -6.04% | United States |
| 123 | Bausch & LombBLCO | $7.14B | $19.96 | -3.11% | Canada |
| 124 | ChemedCHE | $6.97B | $535.44 | -2.41% | United States |
| 125 | Kiniksa Pharmaceuticals InternationalKNSA | $6.95B | $88.42 | -8.01% | United States |
| 126 | Axsome TherapeuticsAXSM | $6.80B | $129.28 | -5.63% | United States |
| 127 | Amneal PharmaceuticalsAMRX | $6.78B | $19.46 | -2.48% | United States |
| 128 | LantheusLNTH | $6.58B | $100.79 | -0.35% | United States |
| 129 | MSA SafetyMSA | $6.56B | $170.33 | -4.10% | United States |
| 130 | TeleflexTFX | $6.46B | $152.52 | +1.77% | United States |
| 131 | Ionis PharmaceuticalsIONS | $6.43B | $38.70 | -3.61% | United States |
| 132 | Oruka TherapeuticsORKA | $6.36B | $96.03 | -5.31% | United States |
| 133 | RadNetRDNT | $6.14B | $78.07 | -2.73% | United States |
| 134 | Mirum PharmaceuticalsMIRM | $6.11B | $93.62 | -3.45% | United States |
| 135 | Ligand PharmaceuticalsLGND | $5.95B | $297.63 | -5.85% | United States |
| 136 | ImmunovantIMVT | $5.87B | $28.44 | -4.90% | United States |
| 137 | GrifolsGRFS | $5.85B | $8.51 | -1.22% | Spain |
| 138 | Belite BioBLTE | $5.76B | $142.93 | -7.20% | United States |
| 139 | CG OncologyCGON | $5.74B | $64.79 | -4.31% | United States |
| 140 | Kodiak SciencesKOD | $5.73B | $91.17 | -7.45% | United States |
| 141 | Hims & Hers HealthHIMS | $5.61B | $24.07 | -9.73% | United States |
| 142 | HaemoneticsHAE | $5.61B | $123.26 | -3.26% | United States |
| 143 | Scholar RockSRRK | $5.56B | $45.63 | -1.01% | United States |
| 144 | Ptc TherapeuticsPTCT | $5.48B | $65.56 | -4.94% | United States |
| 145 | GrailGRAL | $5.38B | $120.49 | -16.13% | United States |
| 146 | VeradermicsMANE | $5.38B | $128.74 | -5.69% | United States |
| 147 | Concentra Group Holdings ParentCON | $5.38B | $42.16 | -3.21% | United States |
| 148 | Merit Medical SystemsMMSI | $5.36B | $89.54 | -1.21% | United States |
| 149 | BillionToOneBLLN | $5.32B | $111.41 | -2.18% | United States |
| 150 | LifeStance Health GroupLFST | $5.15B | $13.49 | -5.10% | United States |
| 151 | Cogent BiosciencesCOGT | $5.14B | $29.61 | -5.97% | United States |
| 152 | MiniMed GroupMMED | $5.14B | $18.26 | -5.34% | United States |
| 153 | LivaNovaLIVN | $5.03B | $91.30 | -3.07% | United Kingdom |
| 154 | Option Care HealthOPCH | $4.73B | $31.56 | -0.30% | United States |
| 155 | CRISPR TherapeuticsCRSP | $4.71B | $48.58 | -6.17% | Switzerland |
| 156 | Travere TherapeuticsTVTX | $4.70B | $49.00 | -6.52% | United States |
| 157 | Dianthus TherapeuticsDNTH | $4.69B | $83.30 | -2.92% | United States |
| 158 | ErascaERAS | $4.64B | $13.27 | -11.03% | United States |
| 159 | Sotera HealthSHC | $4.53B | $15.88 | -3.14% | United States |
| 160 | HeartflowHTFL | $4.50B | $51.79 | -8.45% | United States |
| 161 | Legend BiotechLEGN | $4.39B | $22.56 | -0.94% | United States |
| 162 | Adaptive BiotechnologiesADPT | $4.35B | $26.85 | +0.51% | United States |
| 163 | iRhythmIRTC | $4.32B | $130.93 | -2.29% | United States |
| 164 | IntegerITGR | $4.31B | $126.69 | +0.04% | United States |
| 165 | Edgewise TherapeuticsEWTX | $4.26B | $38.87 | +3.57% | United States |
| 166 | Icu MedicalICUI | $4.19B | $167.65 | -2.88% | United States |
| 167 | Definium TherapeuticsDFTX | $4.09B | $30.43 | -6.96% | United States |
| 168 | EnvistaNVST | $4.00B | $24.93 | -8.33% | United States |
| 169 | CareDxCDNA | $3.99B | $75.99 | -11.49% | United States |
| 170 | LiquidiaLQDA | $3.98B | $44.49 | -6.10% | United States |
| 171 | Pulse BiosciencesPLSE | $3.79B | $53.16 | -6.83% | United States |
| 172 | Relay TherapeuticsRLAY | $3.76B | $17.01 | -5.66% | United States |
| 173 | Xenon PharmaceuticalsXENE | $3.66B | $37.76 | -3.65% | Canada |
| 174 | Acadia PharmaceuticalsACAD | $3.65B | $21.20 | -1.26% | United States |
| 175 | Organon & Co.OGN | $3.63B | $13.81 | -0.14% | United States |
| 176 | AbCellera BiologicsABCL | $3.60B | $11.12 | -9.45% | Canada |
| 177 | Stevanato Group S.p.A.STVN | $3.58B | $13.12 | -2.42% | Italy |
| 178 | Tango TherapeuticsTNGX | $3.52B | $20.91 | -9.81% | United States |
| 179 | Disc MedicineIRON | $3.49B | $78.71 | -5.49% | United States |
| 180 | Iovance BiotherapeuticsIOVA | $3.49B | $7.71 | -11.44% | United States |
| 181 | Amylyx PharmaceuticalsAMLX | $3.48B | $27.75 | -5.61% | United States |
| 182 | Arcutis BiotherapeuticsARQT | $3.42B | $27.01 | -20.68% | United States |
| 183 | Parabilis MedicinesPBLS | $3.41B | $27.94 | -7.97% | United States |
| 184 | Tarsus PharmaceuticalsTARS | $3.33B | $67.59 | -2.15% | United States |
| 185 | Viking TherapeuticsVKTX | $3.29B | $25.80 | -7.78% | United States |
| 186 | Enliven TherapeuticsELVN | $3.28B | $44.73 | -5.33% | United States |
| 187 | National HealthcareNHC | $3.25B | $207.51 | -2.30% | United States |
| 188 | Dyne TherapeuticsDYN | $3.25B | $17.38 | -6.26% | United States |
| 189 | Acadia HealthcareACHC | $3.24B | $34.90 | +8.22% | United States |
| 190 | Viridian TherapeuticsVRDN | $3.24B | $28.54 | -1.77% | United States |
| 191 | Warby ParkerWRBY | $3.22B | $26.03 | +22.26% | United States |
| 192 | Telix PharmaceuticalsTLX | $3.19B | $9.43 | -2.48% | Australia |
| 193 | Denali TherapeuticsDNLI | $3.16B | $19.75 | -5.80% | United States |
| 194 | CelcuityCELC | $3.14B | $64.15 | -7.35% | United States |
| 195 | AtriCureATRC | $3.12B | $61.37 | -6.36% | United States |
| 196 | Privia Health GroupPRVA | $3.05B | $23.89 | +6.63% | United States |
| 197 | Surgery PartnersSGRY | $3.04B | $23.19 | +0.11% | United States |
| 198 | Aveanna HealthcareAVAH | $2.99B | $13.72 | -3.58% | United States |
| 199 | Bausch Health CompaniesBHC | $2.99B | $7.99 | -4.26% | Canada |
| 200 | IDEAYA BiosciencesIDYA | $2.97B | $30.67 | -5.22% | United States |
Showing 101–200 of 1,019 companies. One row per company, with secondary share classes folded into their primary listing.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 498Biotechnology: Biological Products (No Diagnostic Substances) 163Medical Specialities 43Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 28Other Pharmaceuticals 10Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 26Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Medical Electronics 4Ophthalmic Goods 8Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.